TY - T1的早期考虑确定的胸膜缓和可以减少的数量和时间序列胸腔穿刺术JF -欧洲呼吸杂志》乔和J - 10.1183/13993003.国会2016欧元。PA5049六世- 48 - 60 SP - PA5049 AU -坎迪斯威尔希尔AU -卡森富勒盟-罗伯·伊利AU -克里斯托弗·吉尔伯特AU -布莱恩路易盟-拉尔夫赞成非盟-亚历山大Farivar盟-埃里克valliere盟杰德戈登Y1 - 2016/09/01 UR - //www.qdcxjkg.com/content/48/suppl_60/PA5049.abstract N2 -背景许多胸膜积液相关慢性疾病需要重复thoracenteses。这结合病人的卫生保健系统,可能会降低独立和生活质量。目的复发性胸腔积液患者我们旨在比较thoracenteses数量和跨度的胸腔穿刺术治疗仅在那些由串行胸腔穿刺术和那些最终接受明确的胸膜干预。方法我们回顾了病人从2013年到2015年接受治疗复发性胸腔积液(≥3次)。患者分为两组:串行thoracenteses (ST),并与明确的干预(DI)胸腔穿刺术。值中位数(四分位范围)。结果259 hemi-thoraces, DI和98年161年在圣胸腔穿刺术数量是少DI(2 - 4)与圣(4 - 5),p = 0.01。thoracenteses治疗持续时间少DI(21天,8 - 65)和圣(80天,30 - 207),术中;0.01。两组生存后持续胸腔穿刺术超过90天(DI: 101天,29 - 266;与圣:155天,23 - 477; p=0.04). Similar trends were identified when categorized by effusion etiology MalignantBenignST(41%)DI(88%)pST(59%)DI(12%)pThoracenteses, number4(3-5)3(2-4)0.024(3-5)4(2-5)0.29Spanof thoracentesis, days68(17-210)19(7-63)0.0684(49-180)32(16-67)<0.01Survival, days67(8-215)101(25-259)0.98264(41-580)152(44-387)0.19Conclusions Number of thoracenteses and duration of treatment for recurrent pleural effusions was less in patients who ultimately underwent a definitive pleural intervention. Early consideration of definitive pleural intervention may translate into earlier return to independence. ER -